TGFB2
|
1q41
|
rs4846480
|
Severe COPD vs healthy smoker
|
Cho et al. 2014 [34]
|
TNS1
|
2q35
|
rs2571445
|
COPD susceptibility
|
Soler-Artigas et al. 2011 [36]
|
PID1
|
2q36.3
|
rs10498230
|
FEV1/FVC associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
PID1
|
2q36.3
|
rs1435867
|
FEV1/FVC associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
PID1
|
2q36.3
|
rs16825116
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
FAM13A
|
4q22.1
|
rs2869967
|
Chronic Bronchitis COPD vs smoker control
|
Lee et al. 2014 [29]
|
FAM13A
|
4q22.1
|
rs2045517
|
Chronic Bronchitis COPD vs smoker control
|
Lee et al. 2014 [29]
|
FAM13A
|
4q22.1
|
rs7671167
|
Chronic Bronchitis COPD vs smoker control
|
Lee et al. 2014 [29]
|
FAM13A
|
4q22.1
|
rs7671167
|
Airway obstruction in COPD
|
Cho et al. 2012 [32]
|
FAM13A
|
4q22.1
|
rs7671167
|
Emphysema in COPD cohort
|
Pillai et al. 2010 [30]
|
FAM13A
|
4q22.1
|
rs7671167
|
COPD susceptibility
|
Cho et al. 2010 [31]
|
FAM13A
|
4q22.1
|
rs1903003
|
COPD susceptibility
|
Cho et al. 2010 [31]
|
FAM13A
|
4q22.1
|
rs2904259
|
Chronic Bronchitis COPD vs smoker control
|
Lee et al. 2014 [29]
|
FAM13A
|
4q22.1
|
rs2609264
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
FAM13A
|
4q22.1
|
rs2609261
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
FAM13A
|
4q22.1
|
rs2609260
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
FAM13A
|
4q22.1
|
rs4416442
|
Moderate to severe and severe COPD vs healthy smoker
|
Cho et al. 2014 [34]
|
FAM13A
|
4q22.1
|
rs1964516
|
Airway obstruction in COPD
|
Cho et al. 2012 [32]
|
FLJ20184
|
4q24
|
rs17035960
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
FLJ20184
|
4q24
|
rs17036052
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
INTS12
|
4q24
|
rs11727189
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
INTS12
|
4q24
|
rs17036090
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
GSTCD
|
4q24
|
rs10516526
|
COPD susceptibility
|
Soler-Artigas et al. 2011 [36]
|
GSTCD
|
4q24
|
rs10516526
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
GSTCD
|
4q24
|
rs11097901
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
GSTCD
|
4q24
|
rs11728716
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
NPNT
|
4q24
|
rs17036341
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
NPNT
|
4q24
|
rs17331332
|
FEV1 associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
HHIP
|
4q31.21
|
rs13141641
|
Moderate to severe and severe COPD vs healthy smoker
|
Cho et al. 2014 [34]
|
HHIP
|
4q31.21
|
rs12504628
|
COPD susceptibility
|
Soler-Artigas et al. 2011 [36]
|
HHIP
|
4q31.21
|
rs13118928
|
FEV1/FVC, Emphysema and Exacerbations in COPD cohort
|
Pillai et al. 2010 [30]
|
HHIP
|
4q31.21
|
rs13118928
|
COPD susceptibility
|
Cho et al. 2010 [31]
|
HHIP
|
4q31.21
|
rs13118928
|
COPD susceptibility
|
van Durme et al. 2010 [103]
|
HHIP
|
4q31.21
|
rs1828591
|
COPD susceptibility
|
van Durme et al. 2010 [103]
|
HTR4
|
5q32
|
rs7733088
|
Airway obstruction
|
Wilk et al. 2012 [35]
|
HTR4
|
5q32
|
rs3995090
|
COPD susceptibility
|
Soler-Artigas et al. 2011 [36]
|
ADAM19
|
5q33
|
rs2277027
|
FEV1/FVC associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
ADAM19
|
5q33
|
rs1422795
|
FEV1/FVC associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
PPT2
|
6p21
|
rs10947233
|
FEV1/FVC associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
AGER
|
6p21
|
rs2070600
|
FEV1/FVC associated measure - COPD susceptibility
|
Castaldi et al. 2011 [96]
|
ACN9
|
7q21.3
|
rs10231916
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
ACN9
|
7q21.3
|
rs10229181
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
RHOBTB1 - TMEM26
|
10q21.2
|
rs10761570
|
Decline in FEV1 in mild/moderate COPD
|
Hansel et al. 2013 [104]
|
RHOBTB1 - TMEM26
|
10q21.2
|
rs7911302
|
Decline in FEV1 in mild/moderate COPD
|
Hansel et al. 2013 [104]
|
EFCAB4A
|
11p15
|
rs34391416
|
Chronic Bronchitis COPD vs smoker control
|
Lee et al. 2014 [29]
|
CHID1
|
11p15
|
rs147862429
|
Chronic Bronchitis COPD vs smoker control
|
Lee et al. 2014 [29]
|
ANO3
|
11p14.2
|
rs7119465
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
MMP12
|
11q22.2
|
rs626750
|
Severe COPD vs healthy smoker
|
Cho et al. 2014 [34]
|
BICD1
|
12p11.21
|
rs10844154
|
Emphysematous COPD
|
Kong et al. 2011 [105]
|
BICD1
|
12p11.21
|
rs161976
|
Emphysematous COPD
|
Kong et al. 2011 [105]
|
LOC100128066 - TTC6
|
14q21.1
|
rs177852
|
Decline in FEV1 in mild/moderate COPD
|
Hansel et al. 2013 [104]
|
RIN3
|
14q32.12
|
rs754388
|
Moderate to severe and severe COPD vs healthy smoker
|
Cho et al. 2014 [34]
|
IREB2
|
15q25.1
|
rs1062980
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
IREB2
|
15q25.1
|
rs13180
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
IREB2
|
15q25.1
|
rs8034191
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
IREB2
|
15q25.1
|
rs265606
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
PSMA4
|
15q25.1
|
rs2036534
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
AGPHD1 - CHRNA3/5
|
15q25.1
|
11 SNPs
|
Airway obstruction in ever smoker
|
Wilk et al. 2012 [35]
|
CHRNA5
|
15q25.1
|
rs17486278
|
Airway obstruction in all ever/never smoker
|
Wilk et al. 2012 [35]
|
CHRNA3/5
|
15q25.1
|
rs8034191
|
FEV1, FEV1/FVC and Emphysema in COPD cohort
|
Pillai et al. 2010 [30]
|
CHRNA3
|
15q25.1
|
rs12914385
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
CHRNA3
|
15q25.1
|
rs1051730
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
CHRNA3
|
15q25.1
|
rs12914385
|
Moderate to severe and severe COPD
|
Cho et al. 2014 [34]
|
CHRNA3/CHRNA5/IREB2
|
15q25.1
|
rs1062980
|
COPD susceptibility
|
Cho et al. 2010 [31]
|
CHRNA3/CHRNA5/IREB2
|
15q25.1
|
rs13180
|
COPD susceptibility
|
Cho et al. 2010 [31]
|
CHRNA3/5
|
15q25.1
|
rs8034191
|
COPD susceptibility
|
Pillai et al. 2009 [38]
|
CHRNA3/5
|
15q25.1
|
rs1051730
|
COPD susceptibility
|
Pillai et al. 2009 [38]
|
FGF7
|
15q21.2
|
rs12591300
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
FGF7
|
15q21.2
|
rs4480740
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
DTWD1
|
15q21.2
|
rs17404727
|
COPD susceptibility
|
Brehm et al. 2011 [37]
|
MCTP2
|
15q26.2
|
rs8031759
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
AKAP1
|
17q22
|
rs886282
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
SOX9
|
17q24.3
|
rs17178251
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
SOX9
|
17q24.3
|
rs17765644
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
SOX9
|
17q24.3
|
rs11870732
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|
RAB4B - EGLN2
|
19q13
|
rs7937
|
Airway obstruction in COPD
|
Cho et al. 2012 [32]
|
RAB4B - EGLN2
|
19q13
|
rs2604894
|
Airway obstruction in COPD
|
Cho et al. 2012 [32]
|
PDE9A
|
21q22.3
|
rs2269145
|
Lung function gene associated with COPD susceptibilty
|
Kim et al. 2014 [33]
|